bioMérieux S.A.
BMXMFOTCHealthcare● Active
$84.00
+$0.69(+0.83%)
Market Cap$9.9B
P/E Ratio—
52W High$152
52W Low$77.38
bioMérieux S.A. (BMXMF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BMXMF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.07B | $3.98B | $3.67B | $3.59B | $3.38B |
| Cost of Revenue | $1.93B | $1.76B | $1.62B | $1.58B | $1.41B |
| Gross Profit | $2.14B | $2.22B | $2.06B | $2.01B | $2.00B |
| Gross Margin %(computed) | 52.63% | 55.66% | 55.99% | 55.97% | 59.26% |
| Operating Expenses | |||||
| R&D Expenses | $0.51B | $0.49B | $0.54B | $0.45B | $0.39B |
| G&A Expenses | $0.00B | $0.31B | $0.29B | $0.25B | $0.24B |
| Total Operating Expenses | $1.58B | $1.63B | $1.62B | $1.42B | $1.22B |
| Operating Income | $0.56B | $0.59B | $0.44B | $0.59B | $0.78B |
| Operating Margin %(computed) | 13.79% | 14.79% | 11.95% | 16.36% | 23.23% |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.02B | $0.00B | $0.00B | $0.01B |
| Income Before Tax | $0.53B | $0.58B | $0.44B | $0.58B | $0.77B |
| Income Tax Expense | $0.13B | $0.15B | $0.11B | $0.14B | $0.18B |
| Net Income | $0.40B | $0.43B | $0.36B | $0.45B | $0.60B |
| Net Margin %(computed) | 9.77% | 10.86% | 9.73% | 12.61% | 17.80% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.37 | $3.67 | $3.03 | $3.84 | $5.08 |
| Wtd Avg Shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B |
| EBITDA | $1.00B | $0.90B | $0.86B | $0.85B | $1.01B |
| EBITDA Margin %(computed) | 24.56% | 22.55% | 23.34% | 23.76% | 29.77% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more bioMérieux S.A. data
About bioMérieux S.A. (BMXMF) Income Statement
bioMérieux S.A. (BMXMF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BMXMF reported revenue of $4.07B, gross profit of $2.14B (gross margin 52.63%), and net income of $0.40B — a net profit margin of 9.77%.
Frequently asked questions
BMXMF · 4 questionsbioMérieux S.A. (BMXMF) reported revenue of $4.07B for 2025, up 2.2% year-over-year.
BMXMF revenueBMXMF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09